Skip to main content
SpringerLink
Log in

Analysing coverage decision-making: opening Pandora’s box?

  • Editorial
  • Published:
The European Journal of Health Economics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Montori, V.M., Guyatt, G.H.: Progress in evidence-based medicine. JAMA 300(15), 1814–1816 (2008). doi:10.1001/jama.300.15.1814

    Article  CAS  PubMed  Google Scholar 

  2. Stafinski, T., Menon, D., Philippon, D.J., McCabe, C.J.: Health technology funding decision-making processes around the world: the same, yet different. Pharmacoeconomics 29(6), 475–495 (2011). doi:10.2165/11586420-000000000-00000

    Article  PubMed  Google Scholar 

  3. Hutton, J., McGrath, C., Frybourg, J.M., Tremblay, M., Bramley-Harker, E., Henshall, C.: Framework for describing and classifying decision-making systems using technology assessment to determine the reimbursement of health technologies (fourth hurdle systems). Int. J. Technol. Assess. Health Care 22(1), 10–18 (2006). doi:10.1017/S0266462306050781

    Article  PubMed  Google Scholar 

  4. Anell, A.: Priority setting for pharmaceuticals. The use of health economic evidence by reimbursement and clinical guidance committees. Eur. J. Health Econ. 5(1), 28–35 (2004). doi:10.1007/s10198-003-0195-0

    Article  PubMed  Google Scholar 

  5. Velasco-Garrido, M., Zentner, A., Busse, R.: Health systems, health policy and health technology assessment. In: Observatory, E. (ed.) Health Technology Assessment and Health Policy-Making in Europe: Current Status, Challenges and Potential, pp. 53–78. World Health Organization, Copenhagen (2008)

    Google Scholar 

  6. Taylor, R.S., Drummond, M.F., Salkeld, G., Sullivan, S.D.: Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle. BMJ 329(7472), 972–975 (2004). doi:10.1136/bmj.329.7472.972

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Honig, P.K.: Comparative effectiveness: the fourth hurdle in drug development and a role for clinical pharmacology. Clin. Pharmacol. Ther. 89(2), 151–156 (2011). doi:10.1038/clpt.2010.302

    Article  CAS  PubMed  Google Scholar 

  8. Ogilvie, D., Craig, P., Griffin, S., Macintyre, S., Wareham, N.J.: A translational framework for public health research. BMC Public Health 9, 116 (2009). doi:10.1186/1471-2458-9-116

    Article  PubMed Central  PubMed  Google Scholar 

  9. National Centre for Priority Setting in Health Care (2008) Resolving Health Care’s Difficult Choices: Survey of Priority Setting in Sweden and an Analysis of Principles and Guidelines on Priorities in Health Care. National Centre for Priority Setting in Health Care, Linköping

  10. Sabik, L.M., Lie, R.K.: Priority setting in health care: lessons from the experiences of eight countries. Int. J. Equity Health 7, 4 (2008)

    Article  PubMed Central  PubMed  Google Scholar 

  11. Dixit, A.K.: The Making of Economic Policy: A Transaction-Cost Politics Perspective, Munich Lectures, vol. 1. MIT Press, Cambridge (1996)

    Google Scholar 

  12. Thurner, P., Kotzian, P.: Comparative health care systems: outline for an empirical application of new institutional economics approaches. Paper presented at the ECPR meeting. Grenoble, April 2001

  13. Jan, S.: Why does economic analysis in health care not get implemented more? Towards a greater understanding of the rules of the game and the costs of decision making. Appl. Health Econ. Health Policy 2(1), 17–24 (2003)

    PubMed  Google Scholar 

  14. Dewa, C.S., Hoch, J.S.: Fixed and flexible formularies as cost-control mechanisms. Expert Rev. Pharmacoecon. Outcomes Res. 3(3), 303–315 (2003). doi:10.1586/14737167.3.3.303

    Article  PubMed  Google Scholar 

  15. Baio, G., Russo, P.: A decision-theoretic framework for the application of cost-effectiveness analysis in regulatory processes. Pharmacoeconomics 27(8), 645–655 (2009)

    Article  PubMed  Google Scholar 

  16. Hoedemaekers, R., Dekkers, W.: Justice and solidarity in priority setting in health care. Health Care Anal. 11(4), 325–343 (2003)

    Article  PubMed  Google Scholar 

  17. Cookson, R., Dolan, P.: Principles of justice in health care rationing. J. Med. Ethics 26(5), 323–329 (2000)

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Olsen, J.A.: Theories of justice and their implications for priority setting in health care. J. Health Econ. 16(6), 625–639 (1997)

    Article  CAS  PubMed  Google Scholar 

  19. Landwehr, C.: Substantial and procedural justice in the distribution of health goods [in German]. Politische Vierteljahresschrift: Zeitschrift der Deutschen Vereinigung für Politische Wissenschaft 52(1), 29–50 (2011)

    Google Scholar 

  20. Daniels, N., Sabin, J.: The ethics of accountability in managed care reform. Health Aff. 17(5), 50–64 (1998). doi:10.1377/hlthaff.17.5.50

    Article  CAS  Google Scholar 

  21. Jansson, S.: Implementing accountability for reasonableness: the case of pharmaceutical reimbursement in Sweden. Health Econ. Policy Law 2(2), 153–171 (2007). doi:10.1017/S1744133107004082

    Article  PubMed  Google Scholar 

  22. Landwehr, C.: Deciding how to decide: the case of health care rationing. Public Adm. 87(3), 586–603 (2009)

    Article  Google Scholar 

  23. Gress, S., Niebuhr, D., Rothgang, H., Wasem, J.: Criteria and procedures for determining benefit packages in health care. A comparative perspective. Health Policy 73(1), 78–91 (2005). doi:10.1016/j.healthpol.2004.10.005

    Article  PubMed  Google Scholar 

  24. Rogowski, W.: An economic theory of the fourth hurdle. Health Econ. 22(5), 600–610 (2012). doi:10.1002/hec.2830

    Article  PubMed  Google Scholar 

  25. Claxton, K.: The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J. Health Econ. 18(3), 341–364 (1999)

    Article  CAS  PubMed  Google Scholar 

  26. Eddy, D.M.: Clinical decision making: from theory to practice. Anatomy of a decision. JAMA 263(3), 441–443 (1990)

    Article  CAS  PubMed  Google Scholar 

  27. Giacomini, M.: One of these things is not like the others: the idea of precedence in health technology assessment and coverage decisions. Milbank Q. 83(2), 193–223 (2005)

    Article  PubMed Central  PubMed  Google Scholar 

  28. Carlson, J.J., Thariani, R., Roth, J., Gralow, J., Henry, N.L., Esmail, L., Deverka, P., Ramsey, S.D., Baker, L., Veenstra, D.L.: Value-of-information analysis within a stakeholder-driven research prioritization process in a US setting: an application in cancer genomics. Med. Decis. Mak. 33(4), 463–471 (2013). doi:10.1177/0272989x13484388

    Article  Google Scholar 

  29. Baltussen, R., Niessen, L.: Priority setting of health interventions: the need for multi-criteria decision analysis. Cost Eff. Resour. Alloc. 4, 14 (2006). doi:10.1186/1478-7547-4-14

    Article  PubMed Central  PubMed  Google Scholar 

  30. Sibbald, S.L., Singer, P.A., Upshur, R., Martin, D.K.: Priority setting: what constitutes success? A conceptual framework for successful priority setting. BMC Health Serv. Res. 9, 43 (2009)

    Article  PubMed Central  PubMed  Google Scholar 

  31. Russell, J., Greenhalgh, T., Byrne, E., McDonnell, J.: Recognizing rhetoric in health care policy analysis. J. Health Serv. Res. Policy 13(1), 40–46 (2008). doi:10.1258/jhsrp.2007.006029

    Article  PubMed  Google Scholar 

  32. Niessen, L.W., Bridges, J., Lau, B.D., Wilson, R.F., Sharma, R., Walker, D.G., Frick, K.D., Bass, E.B.: Assessing the Impact of Economic Evidence on Policymakers in Health Care–A Systematic Review. AHRQ Publication No. 12(13)-EHC133-EF, Rockville (MD) (2012)

  33. Schreyögg, J., Stargardt, T., Velasco-Garrido, M., Busse, R.: Defining the ‘health benefit basket’ in nine European countries. Evidence from the European Union Health BASKET Project. Eur. J. Health Econ. 6(Suppl 1), 2–10 (2005). doi:10.1007/s10198-005-0312-3

    Article  PubMed Central  Google Scholar 

  34. Fischer, K.E., Grosse, S.D., Rogowski, W.: The role of health technology assessment in coverage decisions on newborn screening. Int. J. Technol. Assess. Health Care 27(4), 305–312 (2011)

    Article  Google Scholar 

  35. Hassenteufel, P., Palier, B.: Towards neo-bismarckian health care states? Comparing health insurance reforms in bismarckian welfare systems. Soc. Pol. Admin. 41(6), 574–596 (2007). doi:10.1111/j.1467-9515.2007.00573.x

    Article  Google Scholar 

  36. Hoedemaekers, R., Dekkers, W.: Key concepts in health care priority setting. Health Care Anal. 11(4), 309–323 (2003)

    Article  PubMed  Google Scholar 

  37. Burgess, L., Terblanche, M.: The future of the pharmaceutical, biological and medical device industry. Open Access J. Clin. Trials 2011(3), 45–50 (2011)

    Google Scholar 

  38. Antonanzas, F., Rodriguez-Ibeas, R., Hutter, M.F., Lorente, R., Juarez, C., Pinillos, M.: Genetic testing in the European Union: does economic evaluation matter? Eur. J. Health Econ. (2011). doi:10.1007/s10198-011-0319-x

    Google Scholar 

  39. McCabe, C., Bergmann, L., Bosanquet, N., Ellis, M., Enzmann, H., von Euler, M., Jonsson, B., Kallen, K.J., Newling, D., Nussler, V., Paschen, B., de Wilde, R., Wilking, N., Teale, C., Zwierzina, H.: Market and patient access to new oncology products in Europe: a current, multidisciplinary perspective. Ann. Oncol. 20(3), 403–412 (2009). doi:10.1093/annonc/mdn603

    Article  CAS  PubMed  Google Scholar 

  40. Heal, D.J., Gosden, J., Smith, S.L.: Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders. Br. J. Clin. Pharmacol. 68(6), 861–874 (2009). doi:10.1111/j.1365-2125.2009.03549.x

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  41. Kanavos, P., Nicod, E., van den Aardweg, S., Pomedli, S.: The impact of health technology assessments: an international comparison. Euro Obs. 12(4), 1–7 (2010)

    Google Scholar 

  42. Le Polain, M., Franken, M., Koopmanschap, M.A., Cleemput, I.: Drug reimbursement systems: international comparison and policy recommendations. KCE reports 147C, D/2010/10.273/90. Belgian Health Care Knowledge Centre (KCE), Brussels, (2010)

  43. Fischer, K.E.: A systematic review of coverage decision-making on health technologies: evidence from the real-world. Health Policy 107(2–3), 218–230 (2012). doi:10.1016/j.healthpol.2012.07.005

    Article  PubMed  Google Scholar 

  44. Fischer, K.E., Leidl, R., Rogowski, W.H.: A structured tool to analyse coverage decisions: development and feasibility test in the field of cancer screening and prevention. Health Policy 101(3), 290–299 (2011). doi:10.1016/j.healthpol.2011.03.002

    Article  PubMed  Google Scholar 

  45. Rogowski, W.H., Hartz, S.C., John, J.H.: Clearing up the hazy road from bench to bedside: a framework for integrating the fourth hurdle into translational medicine. BMC Health Serv. Res. 8, 194 (2008). doi:10.1186/1472-6963-8-194

    Article  PubMed Central  PubMed  Google Scholar 

  46. Stolk, E.A., de Bont, A., van Halteren, A.R., Bijlmer, R.J., Poley, M.J.: Role of health technology assessment in shaping the benefits package in the Netherlands. Expert Rev. Pharmacoecon. Outcomes Res. 9(1), 85–94 (2009). doi:10.1586/14737167.9.1.85

    Article  PubMed  Google Scholar 

  47. Franken, M., le Polain, M., Cleemput, I., Koopmanschap, M.: Similarities and differences between five European drug reimbursement systems. Int. J. Technol. Assess. Health Care 28(4), 349–357 (2012). doi:10.1017/S0266462312000530

    Article  PubMed  Google Scholar 

  48. Fischer, K.E., Rogowski, W., Leidl, R., Stollenwerk, B.: Transparency vs. closed-door policy: do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis. Health Policy 112(3), 187–196 (2013). doi:10.1016/j.healthpol.2013.04.011

    Article  PubMed  Google Scholar 

  49. Vuorenkoski, L., Toiviainen, H., Hemminki, E.: Decision-making in priority setting for medicines: a review of empirical studies. Health Policy 86(1), 1–9 (2008). doi:10.1016/j.healthpol.2007.09.007

    Article  PubMed  Google Scholar 

  50. Devlin, N.J., Parkin, D.: Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. Health Econ 13(5), 437–452 (2004). doi:10.1002/hec.864

    Article  PubMed  Google Scholar 

  51. Dakin, H.A., Devlin, N.J., Odeyemi, I.A.: ‘Yes’, ‘No’ or ‘Yes, but’? Multinomial modelling of NICE decision-making. Health Policy 77(3), 352–367 (2006). doi:10.1016/j.healthpol.2005.08.008

    Article  PubMed  Google Scholar 

  52. Rocchi, A., Miller, E., Hopkins, R.B., Goeree, R.: Common drug review recommendations: an evidence base for expectations? Pharmacoeconomics 30(3), 229–246 (2012). doi:10.2165/11593030-000000000-00000

    Article  PubMed  Google Scholar 

  53. Park, S.E., Lim, S.H., Choi, H.W., Lee, S.M., Kim, D.W., Yim, E.Y., Kim, K.H., Yi, S.Y.: Evaluation on the first 2 years of the positive list system in South Korea. Health Policy 104(1), 32–39 (2012). doi:10.1016/j.healthpol.2011.09.006

    Article  PubMed  Google Scholar 

  54. Fischer, K.E.: Decision-making in healthcare: a practical application of partial least square path modelling to coverage of newborn screening programmes. BMC Med. Inf. Dec. Mak. 12(1), 83 (2012)

    Article  Google Scholar 

  55. Fischer, K.E., Stollenwerk, B., Rogowski, W.: Link between process and appraisal in coverage decisions: an analysis with structural equation modeling. Med. Decis. Mak. 33(8), 1009–1025 (2013). doi:10.1177/0272989X13490837

    Article  Google Scholar 

  56. Ratcliffe, J., Bekker, H.L., Dolan, P., Edlin, R.: Examining the attitudes and preferences of health care decision-makers in relation to access, equity and cost-effectiveness: a discrete choice experiment. Health Policy 90(1), 45–57 (2009). doi:10.1016/j.healthpol.2008.09.001

    Article  PubMed  Google Scholar 

  57. Koopmanschap, M.A., Stolk, E.A., Koolman, X.: Dear policy maker: have you made up your mind? A discrete choice experiment among policy makers and other health professionals. Int. J. Tech. Assess. Health Care 26(2), 198–204 (2010). doi:10.1017/S0266462310000048

    Article  Google Scholar 

  58. Mirelman, A., Mentzakis, E., Kinter, E., Paolucci, F., Fordham, R., Ozawa, S., Ferraz, M., Baltussen, R., Niessen, L.W.: Decision-making criteria among national policymakers in five countries: a discrete choice experiment eliciting relative preferences for equity and efficiency. Value Health 15(3), 534–539 (2012). doi:10.1016/j.jval.2012.04.001

    Article  PubMed  Google Scholar 

  59. Kelly, M.P., Moore, T.A.: The judgement process in evidence-based medicine and health technology assessment. Soc.Theory Health 10(1), 1–19 (2012). doi:10.1057/sth.2011.21

    Article  PubMed Central  PubMed  Google Scholar 

  60. Zweifel, P.: The present state of health economics: a critique and an agenda for the future. Eur. J. Health Econ. 14(4), 569–571 (2013). doi:10.1007/s10198-012-0427-2

    Article  PubMed  Google Scholar 

  61. Mahajan, V., Muller, E., Bass, F.M.: New product diffusion models in marketing: A review and directions for research. J. Mark. 54(1), 1–26 (1990)

    Google Scholar 

  62. Peres, R., Muller, E., Mahajan, V.: Innovation diffusion and new product growth models: a critical review and research directions. Int. J. Res. Mark. 27(2), 91–106 (2010). doi:10.1016/j.ijresmar.2009.12.012

    Article  Google Scholar 

  63. Stremersch, S., Van Dyck, W.: Marketing of the life sciences: a new framework and research agenda for a nascent field. J. Mark. 73(4), 4–30 (2009). doi:10.1509/jmkg.73.4.4

    Article  Google Scholar 

  64. Fendrick, A.M., Martin, J.J., Weiss, A.E.: Value-based insurance design: more health at any price. Health Serv. Res. 47(1pt2), 404–413 (2012). doi:10.1111/j.1475-6773.2011.01358.x

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hamburg Center for Health Economics, Universität Hamburg, Esplanade 36, 20354, Hamburg, Germany

    Katharina Elisabeth Fischer

  2. Institute of Health Economics and Health Care Management, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany

    Katharina Elisabeth Fischer & Reiner Leidl

  3. Munich Center of Health Sciences, Ludwig-Maximilians-University, Ludwigstr. 28, 80539, Munich, Germany

    Reiner Leidl

Authors
  1. Katharina Elisabeth Fischer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Reiner Leidl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Katharina Elisabeth Fischer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fischer, K.E., Leidl, R. Analysing coverage decision-making: opening Pandora’s box?. Eur J Health Econ 15, 899–906 (2014). https://doi.org/10.1007/s10198-014-0566-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10198-014-0566-8

Search

Navigation